Home » Novo Nordisk Executive Sees Inhaled Insulin as Niche Product
Novo Nordisk Executive Sees Inhaled Insulin as Niche Product
Pfizer Inc.’s (PFE) recent decision to stop selling the first inhaled form of insulin cast a shadow over the future of such diabetes treatments, which rival companies have been developing.
CNN Money
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May